ELONEX AND RYFF ANNOUNCE IN-SCENE OUT-OF-HOME ADVERTISING PARTNERSHIP AT MAD//Fest
First-of-Its Kind Advertising Model Offers Brands Screen-to-Screen Reach
from Billboard to Broadcast
A combined media buy across both digital out-of-home and in-scene properties allows brands to achieve valuable repetition, contextual relevance, and deeper, more meaningful engagements with their target audience.
In addition, this powerful combination allows advertisers to:
- Target specific audiences - place in-scene billboards into the TV shows and movies their ideal demographic is watching.
- Increase visibility - scale DOOH campaigns into a wide range of video content, securing higher viewership.
- Move fast - change ads or messaging in near real-time, with brand integrations completed in minutes across both DOOH and In-Scene placements.
Ryff's Scene Intelligence™ technology enables the discovery of complementary in-scene billboard placement opportunities that align with geographic, demographic, and messaging targets, among other factors. Campaigns created through this partnership are backed by robust data and performance analytics, ensuring effective, trackable, and measurable outcomes that optimize ad spending.
The innovative approach to advertising is being introduced in the
About Ryff
Based in
About Elonex
Elonex operate a unique DOOH Advertising Network, which stretches across multiple lifestyle environments to make it easy for brands of all sizes to reach, target and engage with the most clearly defined audiences. With a long and successful history of developing and advancing new technology, bringing new e-concepts to market and leading modern-day innovation, Elonex is committed to building brands, propelling brand messages and maximising brand engagement through the power of high impact digital visual communication.
View original content to download multimedia:https://www.prnewswire.com/news-releases/elonex-and-ryff-announce-in-scene-out-of-home-advertising-partnership-at-madfest-302188025.html
SOURCE Ryff Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference�
- MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings
- Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share